Approvals/CIMA-AEMPS/ANORO ELLIPTA 55 MCG/22 MCG POLVO PARA INHALACION (UNIDOSIS)

Approved

STANDARD

ANORO ELLIPTA 55 MCG/22 MCG POLVO PARA INHALACION (UNIDOSIS)

Glaxosmithkline (Ireland) Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 8ceb00d4ec53dab9
Drug Cima Aemps Name: ANORO ELLIPTA 55 MCG/22 MCG POLVO PARA INHALACION (UNIDOSIS)
Register Number: 114898002IP5
Holder Company Name: Glaxosmithkline (Ireland) Limited
Marketing Company Name: Orifarm A/S
Holder Company Detail Path: /organization/glaxosmithkline-ireland-limited
Authorization Date: 2025-10-10
Dosage Form: POLVO PARA INHALACIÓN (UNIDOSIS)
Dose: 55 MICROGRAMOS/22 MICROGRAMOS
Route Of Administration: VÍA INHALATORIA
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Glaxosmithkline (Ireland) Limited
Company Detail Path: /organization/glaxosmithkline-ireland-limited

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Oct 10, 2025

Approval ID

8ceb00d4ec53dab9

Type

Standard